GDF15 and congenital heart disease: Elevated GDF15 is an early marker of anthracycline-induced cardiac dysfunction in survivors of pediatric cancers and a predictor for all-cause mortality in children with congenital heart disease, and this pilot data suggest that the earlier study of inflammatory markers such as GDF15 in children undergoing cancer treatment may be warranted (23).